Cardiff Oncology, Inc. (CRDF)
2.81
-0.06
(-2.09%)
USD |
NASDAQ |
Dec 31, 16:00
2.81
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Free Cash Flow: -42.27M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -89.31M |
| AIM ImmunoTech, Inc. | -13.33M |
| Perspective Therapeutics, Inc. | -106.85M |
| Protalix Biotherapeutics, Inc. | -11.69M |
| Armata Pharmaceuticals, Inc. | -27.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.83M |
| Cash from Investing (Quarterly) | 10.16M |
| Cash from Financing (Quarterly) | 0.025M |
| Free Cash Flow Per Share (Quarterly) | -0.1623 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | -10.85M |
| Free Cash Flow Yield | -23.58% |